BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220307T133000
DTEND;TZID=America/New_York:20220307T150000
DTSTAMP:20220305T134424Z
CREATED:20220303T133528Z
LAST-MODIFIED:20220305T134424Z
UID:54171-1646659800-1646665200@globalbiodefense.com
SUMMARY:National Biodefense Science Board Public Meeting
DESCRIPTION:The next public meeting of the National Biodefense Science Board (NBSB) will take place Monday\, 7 March 2022 from 1:30pm – 3:00pm ET via Zoom. \nJoin federal leaders\, National Biodefense Science Board members\, distinguished guests\, and other experts to discuss topics related to the public health supply chain and climate change.  NBSB will hear from the HHS Office of Climate Change and Health Equity and Joint Program Executive Office for Chemical\, Biological\, Radiological\, and Nuclear Defense (JPEO-CBRND) during the meeting. \nSubject matter experts from industry; academia; health systems; health consumer organizations; state\, local\, tribal\, and territorial public health; and emergency management agencies will also have an opportunity to provide comments to the NBSB on national priorities for biodefense and health security. Individual remarks will be limited to seven minutes each and the display of images and/or slides for public speakers will not be available. \nRequests to provide remarks to the NBSB during the public meeting must be sent to NBSB@hhs.gov by March 4\, 2022. In that request\, please provide the speaker’s name\, title\, and position with a brief summary of planned comments. The number of speakers and topics will be based on relevance to the mission of the NBSB and amount of time available on the agenda.  Those selected for public comments will receive confirmation by email prior to the meeting date with additional instructions. \nRegistration for this event is required and can be accessed along with additional meeting information through the online event page.  We encourage you to share this engagement information broadly across your network in advance of the meeting. \nMeeting materials will be made available to the public on the National Biodefense Science Board webpage. For any additional information or questions specific to this event\, please contact NBSB@hhs.gov directly.
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting-3/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://hhsasproea.zoomgov.com/webinar/register/WN_DdvW3yVpTuGWSIey8ZsfBg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220425T070000
DTEND;TZID=America/New_York:20220425T163000
DTSTAMP:20220422T174133Z
CREATED:20220422T174133Z
LAST-MODIFIED:20220422T174133Z
UID:54835-1650870000-1650904200@globalbiodefense.com
SUMMARY:Malaria in Africa: Translating Science Into Practice
DESCRIPTION:The Johns Hopkins Malaria Research Institute will host a World Malaria Day Symposium on 25 April 2022 featuring presentations by the five NIH International Centers of Excellence for Malaria Research (ICEMRs) that are actively working in Africa in the countries of Mali\, Uganda\, Ethiopia\, Kenya\, Malawi\, Mozambique\, Democratic Republic of Congo\, Zimbabwe\, and Zambia. \nCONFIRMED KEYNOTE SPEAKERS \n\nDr. Matshidiso Rebecca Moeti\, Regional Director for Africa\, World Health Organization\n“Science\, research and precision disease control with malaria as entry point”\nDr. Rick Steketee\, Deputy U.S. Global Malaria Coordinator\, U.S. President’s Malaria Initiative\n“Malaria science and program: challenging topics of climate and localization”\nProfessor Sheila Tlou\, ALMA Special Ambassador\, African Leaders Malaria Alliance\n“ALMAs 4-point agenda in the fight against malaria: linking policy\, accountability and action to science”\n\nThe Johns Hopkins Malaria Research Institute’s state-of-the-art facility is the hub for a community of multidisciplinary researchers dedicated to treat\, control and eradicate this deadly disease. Focused on four major areas of research: Entomology\, Parasitology\, Epidemiology and Immunology\, JHMRI boasts experts from around the globe\, all working to prevent and cure malaria. \nPlease visit the Johns Hopkins Malaria Research Institute World Malaria Day Symposium event page to register for the event
URL:https://globalbiodefense.com/event/malaria-in-africa-translating-science-into-practice/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2022/04/world-malaria-day-johns-hopkins.png
LOCATION:https://jh.zoom.us/webinar/register/WN_KEnjPeZNT8OkDXaSNvYniA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220503
DTEND;VALUE=DATE:20220507
DTSTAMP:20220420T214323Z
CREATED:20220420T213804Z
LAST-MODIFIED:20220420T214323Z
UID:54802-1651536000-1651881599@globalbiodefense.com
SUMMARY:ABSA 2nd Biosecurity Symposium
DESCRIPTION:ABSA International will host the 2nd Biosecurity Hybrid Symposium 3-6 May 2022 in a hybrid virtual and in-person format in Minneapolis\, Minnesota. \nThe hybrid symposium will consist of papers\, presentations\, keynotes\, posters\, valuable networking opportunities\, and in-person exhibits. Attendees may register for the in-person event or the virtual event. \nThe event will gather biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge and to learn from each other. The agenda includes themes on biosecurity governance\, implementation\, personnel reliability\, bioeconomy\, biosecurity in DIYbio communities\, biosecurity training\, cyberbiosecurity\, and interactive discussions on lessons learned and public engagement for the future. \nThe symposium will showcase thought-provoking leaders and pioneering researchers from various traditional and non-traditional fields that intersect with biosecurity. A segment on new and emerging topics in biosecurity will also be featured. \nHighlighted sessions include: \n\nBiosecurity: Past\, Present\, and Future: Vibeke Halkjaer-Knudsen\, PhD\, Sandia National Laboratories\, Albuquerque\, NM\nEnhancing Security for Emerging Biotechnologies through Collaboratively Designed Exercises: Julie E. Fischer\, PhD\, CRDF Global\, Arlington\, VA\nPreventing Future Pandemics: The Critical Role of Biosecurity in Global Health Security: Samantha Dittrich\, PhD\, Merrick & Company\, Arlington\, VA\nEnhancing Biosecurity Globally Through Implementation of Personal Reliability Programs: Brittany Linkous\, MS\, Merrick & Company\, Arlington\, VA\nBiosecurity and the Bioeconomy: J. Bradley Dickerson\, PhD\, Sandia National Laboratories\, Albuquerque\, NM\nLab Design Matters: Maria Landron\, DrPH\, Association of Public Health Laboratories (APHL)\, Silver Spring\, MD\nTianjin Biosecurity Guidelines for Codes of Conduct for Scientists: Gigi Kwik Gronvall\, PhD\, Johns Hopkins Center for Health Security\, Baltimore\, MD\nConcentric by Ginkgo: Building a Biosecurity and Public Health Platform for the Present and Future: Brian Renda\, PhD\, Ginkgo Bioworks\, Boston\, MA\nRegional Legal Framework as a Basis and an Enhancer of Biosafety and Biosecurity in the African Union Member States: Jaures Arnaud Noumedem Kenfack\, Africa Centers for Diseases Control and Prevention\, Abuja\, Nigeria\nInfectious Disease as a Security Threat and the Role of Public Health Emergency Management in Biodefense and Biosecurity: A COVID-19 Case Study: Ryan S. Houser\, MS\, MPH\, Tetra Tech\, Parsippany\, NJ\nBiosecurity Capacity Building Through a Biosecurity Champions Fellowship Program in Pakistan: Samreen Sarwar\, M.Phil\, Health Security Partners\, Lahore\, Pakistan\nIdentifying and Avoiding Common Mistakes in Risk and Threat Management: Lauren Richardson\, DVM\, MPH\, Merrick and Company\, Arlington\, VA\nBeyond Training: Using Behavioral Science to Motivate Proactive Biorisk Management: Daniel Greene\, PhD\, Stanford University\, Stanford\, CA\nCommunity Driven Genome Engineering Biosecurity Workshop: Industry Practices\, Resources\, and Opportunities: Beth Vitalis\, Inscripta\, Boulder\, CO\n\nPlease visit ABSA International’s 2nd Biosecurity Symposium website to register.
URL:https://globalbiodefense.com/event/absa-2nd-biosecurity-symposium/
LOCATION:Renaissanc Minneapolis Hotel\, The Depot\, 225 3rd Ave S\, Minneapolis\, MN\, 55401-2524\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220503T140000
DTEND;TZID=America/New_York:20220503T150000
DTSTAMP:20220420T201056Z
CREATED:20220420T200824Z
LAST-MODIFIED:20220420T201056Z
UID:54789-1651586400-1651590000@globalbiodefense.com
SUMMARY:COVID-19 Testing Toolkit Webinar: University Testing Strategies
DESCRIPTION:Join the Johns Hopkins Center for Health Security’s COVID-19 Testing Toolkit for a webinar where panelists will discuss how Johns Hopkins University developed and implemented its COVID-19 testing strategies for faculty\, staff\, and students \nMODERATOR \nGigi Gronvall\, PhD\, Senior Scholar\, Johns Hopkins Center for Health Security; Lead\, COVID-19 Testing Toolkit and Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health \nPANELISTS \nStephen Gange\, PhD\, Professor of Epidemiology in the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine\, and Executive Vice Provost for Academic Affairs\, Johns Hopkins University \nJonathan Links\, PhD\, Professor of Environmental Health and Engineering in the Johns Hopkins Bloomberg School of Public Health \, with joint professorial appointments in the schools of Medicine\, Education\, Engineering\, and Business\, and Vice Provost and Chief Risk Officer\, Johns Hopkins University \nLainie Rutkow\, JD\, PhD\, Professor of Health Policy and Management in the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine\, and Vice Provost for Interdisciplinary Initiatives\, Johns Hopkins University. \nThe moderated discussion will be followed by a Q&A session. Media are invited. \nLearn more about this event and register HERE.
URL:https://globalbiodefense.com/event/covid-19-testing-toolkit-webinar-university-testing-strategies/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://jh.zoom.us/webinar/register/WN_I19cGA6FSNWGPHt_6xaYCA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220504T120000
DTEND;TZID=America/New_York:20220504T133000
DTSTAMP:20220422T200622Z
CREATED:20220422T195642Z
LAST-MODIFIED:20220422T200622Z
UID:54839-1651665600-1651671000@globalbiodefense.com
SUMMARY:Biological Risks and Hazards in the World Today - Special Focus on Russia and Ukraine
DESCRIPTION:An expert panel on Biological Risks and Hazards in the World Today with a Special Focus on Russia and Ukraine will be held on 4 May 2022 via webcast. \nTopics will include the health security environment in the post-Soviet states\, as assessed by the Global Health Security Index of 2019 and 2021\, and the biological risks posed by Russia’s invasion of Ukraine and associated disinformation campaign. \nJessica Bell and Hayley Secerance\, of the Nuclear Threat Initiative\, will discuss health security environment across the post-Soviet states. \nGregory Koblentz of George Mason University will address the evolving biosecurity landscape. \nHon. Andrew Weber of the Council on Strategic Risks and former Assistant Secretary of Defense for the Obama Administration will discuss what we know and what we don’t know about the Russian Federation’s biological and chemical weapons’ program. \nRebecca Katz of Georgetown University and Ian Lipkin of Columbia University round out the event. \nThe webinar will be moderated by Wilmot James. \nPlease visit the Columbia University Institute for Social and Economic Research and Policy (ISERP) Biological Risks and Hazards in the World Today event page to register.
URL:https://globalbiodefense.com/event/iserp-biological-risk-hazards-russia-ukraine/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://columbiauniversity.zoom.us/webinar/register/WN_EalzNo1oQw6zWvNG-iWjvA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220517
DTEND;VALUE=DATE:20220519
DTSTAMP:20220422T205702Z
CREATED:20220422T205336Z
LAST-MODIFIED:20220422T205702Z
UID:54847-1652745600-1652918399@globalbiodefense.com
SUMMARY:What Happened to the Plans? Lessons Observed from COVID-19 - A Workshop
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and convene a day and half public health workshop. During this workshop\, invited participants from government\, NGO\, and private sector organizations will explore the nation’s Public Health Emergency (PHE) preparedness enterprise\, including existing PHE preparedness and response plans\, systems\, and structures\, through the lens the COVID-19 response in the United States. \nThe activity will explore key components\, success stories\, as well as failure points throughout the entire PHE preparedness and response enterprise in order to identify opportunities for more effective catastrophic disaster\, pandemic\, and other large scale PHEs planning at the federal\, state\, local\, tribal\, and territorial levels. Using key components of past NASEM reports to frame workshop discussions\, participants will examine specific lessons learned from the COVID-19 pandemic and explore potential paths forward. Specifically\, the workshop will examine: \nWeaknesses and opportunities in the PHE’s systems architecture\, including but not limited to \n\nGlobal disease surveillance;\nHealthcare delivery and core public health functions;\nSupply chain viability and vulnerabilities;\nMedical Counter Measure (MCM) development\, distribution & administration/delivery;\nData systems and other promising opportunities for preparedness and response technology platforms etc.\n\nThe continuum of local-state-regional-national coordination challenges and leadership incident command structure disparities\, including: \n\nPreparedness and response capabilities\, authorities\, and funding streams;\nStaffing challenges and potentially strength of community partnerships to assist in preparedness\, community organizing and vaccine advocacy; and\nRisk communication and messaging failures.\n\nThe planning committee will define the specific topics to be addressed\, develop the agendas\, and select and invite speakers and other participants. After the workshop\, a proceedings-in-brief will be prepared. \nPlease visit the National Academies’ What Happened to the Plans? Lessons Observed from COVID-19 and the Future of the Public Health Emergency Enterprise – A Workshop webpage for more information.
URL:https://globalbiodefense.com/event/what-happened-to-the-plans-lessons-observed-from-covid-19-a-workshop/
LOCATION:National Academies of Sciences\, 2101 Constitution Ave NW\, Washington\, DC\, 20418\, United States
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220524T130000
DTEND;TZID=America/Los_Angeles:20220524T140000
DTSTAMP:20220420T223007Z
CREATED:20220420T223007Z
LAST-MODIFIED:20220420T223007Z
UID:54810-1653397200-1653400800@globalbiodefense.com
SUMMARY:Disease\, Diplomacy and Displacement: Syrian Refugees and the Politics of Health in Jordan
DESCRIPTION:Stanford University’s Center for International Security and Cooperation (CISAC) will host a lecture event on Disease\, Diplomacy and Displacement: Syrian Refugees and the Politics of Health in Jordan on 24 May 2022. \nThe event is open to the public through a virtual option. Those with an active Stanford ID may attend in person at Encina Hall. \nAbout the Speaker: \nSigrid Lupieri is a postdoctoral at the Center for International Security and Cooperation. Dr.Lupieri received her Ph.D. from the Center of Development Studies at the University of Cambridge. She also holds an MPhil in Modern European History from the University of Cambridge and an M.S. in Journalism from Northwestern University. Her primary research investigates how security concerns\, foreign policy agendas\, and diplomacy shape the priorities of refugee responses. In her current book project\, based on the case study of the Syrian refugee crisis in the Middle East\, she finds that security and diplomatic interests have wide-ranging effects on humanitarian health spending\, including a disproportionate focus on infectious diseases and the inequitable distribution of resources. In other research\, Dr. Lupieri explores the impact of refugee movements on the healthcare systems of host countries\, and the intended and unintended effects of international aid on refugee welfare. Outside of academia\, she has worked for several years as a journalist in Armenia\, Georgia\, and Germany\, and as a UN officer in New York and New Delhi. the Senior Director and Lead Scientist\, Global Biological Policy and Programs at NTI. \nPlease visit CISAC’s Disease\, Diplomacy and Displacement: Syrian Refugees and the Politics of Health in Jordan event listing to register.
URL:https://globalbiodefense.com/event/disease-diplomacy-and-displacement-syrian-refugees-and-the-politics-of-health-in-jordan/
LOCATION:Encina Hall\, 616 Jane Stanford Way\, Stanford\, CA\, 94305-6055\, United States
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220602T132000
DTEND;TZID=America/New_York:20220602T154500
DTSTAMP:20220601T173444Z
CREATED:20220601T173444Z
LAST-MODIFIED:20220601T173444Z
UID:55587-1654176000-1654184700@globalbiodefense.com
SUMMARY:Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape
DESCRIPTION:The National Academies’ Board on Life Sciences is pleased to present two discussions – Bioeconomy of the Future and Changing Landscape of Life Science Research Laboratories – to explore critical and emerging issues with the bioeconomy and privately-sponsored basic life sciences research. \nThe life sciences research landscape is changing rapidly as new investments in the bioeconomy drive convergence among science and technology fields to develop new products and services\, and as basic research laboratories are established by private investors. \nThe Bioeconomy of the Future will explore: \n\nChanges that have taken place since publication of the National Bioeconomy Blueprint (2012)\, Safeguarding the Bioeconomy (2020)\, and The Bio Revolution: Innovations Transforming Economies\, Societies\, and our Lives (2020)\nImmediate and near-term developments associated with the bioeconomy\nFuture needs for realizing the full potential of the bioeconomy\nOutstanding needs for protecting and promoting the bioeconomy long-term\n\nFeatured Speakers \n\nMary Maxon\, Schmidt Futures\nAndrea Hodgson\, Schmidt Futures\nMichael Chui\, McKinsey & Company\n\nThe Changing Landscape of Life Sciences Research Laboratories will explore: \n\nShifts in the landscape of life sciences research based on the emergence of research institutes funded by for-profit companies\nThe benefits to the shifting life sciences research landscape\nPossible trade-offs related to life sciences research that are conducted at for-profit institutions\nEmerging trends in life science research landscape and how they relate to current and future public policy\nFuture workforce needs and how education might change to support these new institutions\n\nPlease visit the National Academies’ Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape event page for more information.
URL:https://globalbiodefense.com/event/future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://www.nationalacademies.org/event/06-02-2022/board-on-life-sciences-open-webinar-future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T180000
DTEND;TZID=America/New_York:20220608T180000
DTSTAMP:20220527T184920Z
CREATED:20220527T184920Z
LAST-MODIFIED:20220527T184920Z
UID:55106-1654711200-1654711200@globalbiodefense.com
SUMMARY:GMU Schar School of Policy and Government Virtual Open House
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will host a Master’s and Certificate Virtual Open House on June 8\, 2022 from 6:00 pm – 8:00 pm. \nThe event will provide an overview of available master’s degree programs and highlight GMU’s world-class faculty and research. Admissions and student services staff will be on hand to answer questions. \nThis event is the perfect opportunity to: \n\nExplore Schar School’s top-ranked master’s degree and graduate certificate programs\nLearn about your program of interest in depth\, including the curriculum\, admissions requirements\, and career opportunities\nAsk admissions team members specific questions about the application process\n\nBreakout sessions hosted by program directors and faculty will be available based on your primary program of interest: \nMaster’s in Biodefense\nMaster’s in International Commerce and Policy\nMaster’s in International Security\nMaster’s in Organization Development and Knowledge Management\nMaster’s in Political Science\nMaster’s in Public Administration (MPA)\nMaster’s in Public Policy (MPP) \nBiodefense Certificate\nEmergency Management and Homeland Security Certificate\nGlobal Health and Security Certificate\nIllicit Trade Analysis Certificate\nNational Security and Public Policy Certificate\nNonprofit Management Certificate\nPublic Management Certificate\nScience\, Technology\, and Security Certificate\nStrategic Trade Certificate\nTerrorism and Homeland Security Certificate \nFind more information and register to attend here. \nGlobal Biodefense is an official media partner of the GMU Schar School Biodefense program.
URL:https://globalbiodefense.com/event/gmu-schar-school-of-policy-and-government-virtual-open-house/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/05/schar-school-open-house-june-2022.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220614T083000
DTEND;TZID=America/New_York:20220614T170000
DTSTAMP:20220527T205853Z
CREATED:20220527T205356Z
LAST-MODIFIED:20220527T205853Z
UID:55113-1655195400-1655226000@globalbiodefense.com
SUMMARY:VRBPAC Meeting to Review Moderna Pediatric (Ages 6-17) mRNA Vaccine EAU
DESCRIPTION:The VRBPAC committee will meet in open session on June 14\, 2022 to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age. \nFDA intends to make background material available to the public no later than 2 business days before the meeting.  If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The Docket Number is FDA-2022-N-0904 \nOn June 15\, 2022\, under Topic II\, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age\, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age. \n  \n  \n 
URL:https://globalbiodefense.com/event/vrbpac-meeting-to-review-moderna-pediatric-ages-6-17-mrna-vaccine-eau/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=GbNpaZeDPiA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220615T083000
DTEND;TZID=America/New_York:20220615T170000
DTSTAMP:20220527T210409Z
CREATED:20220527T210409Z
LAST-MODIFIED:20220527T210409Z
UID:55115-1655281800-1655312400@globalbiodefense.com
SUMMARY:VRBPAC Meeting to Review Pediatric (Infant - 5 Years) mRNA Vaccines
DESCRIPTION:The VRBPAC will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age\, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age. \nFDA intends to make background material available to the public no later than 2 business days before the meeting.  If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The Docket Number is FDA-2022-N-0904.
URL:https://globalbiodefense.com/event/vrbpac-meeting-to-review-pediatric-infant-5-years-mrna-vaccines/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=Ixm4UmldTGQ
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220628T083000
DTEND;TZID=America/New_York:20220628T170000
DTSTAMP:20220527T213139Z
CREATED:20220527T213139Z
LAST-MODIFIED:20220527T213139Z
UID:55118-1656405000-1656435600@globalbiodefense.com
SUMMARY:VRBPAC Meeting on COVID-19 Vaccine Strain Composition Decisions
DESCRIPTION:The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. \nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. \nThe Docket Number is FDA-2022-N-0905
URL:https://globalbiodefense.com/event/vrbpac-meeting-on-covid-19-vaccine-strain-composition-decisions/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=BFdzNUus_CE
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220830T083000
DTEND;TZID=America/New_York:20220830T170000
DTSTAMP:20240623T192753Z
CREATED:20220829T230154Z
LAST-MODIFIED:20240623T192753Z
UID:56260-1661848200-1661878800@globalbiodefense.com
SUMMARY:Drug Development Considerations for the Prevention of Healthcare Associated Infections
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop on August 30\, 2022. All meeting materials—including agenda\, panelist affiliations/disclosures\, speaker slides\, workshop recording\, and transcript—will be posted here shortly before and/or after the completion of the workshop. \n\nThe current state of development of pathogen-directed products used to prevent healthcare-associated infections (HAIs).\nEvidence supporting decolonization and pathogen reduction (in colonized patients) as a strategy to prevent infection and transmission of antimicrobial-resistant healthcare-associated pathogens.\nAntimicrobial resistance threats as potential targets for decolonization and pathogen reduction.\nChallenges and potential approaches to drug development and registration of products for the prevention of healthcare-associated infections.\n\nThis meeting will be held in virtual format only. Registration is required for online attendance and will be available until 12 p.m. EDT on August 29\, 2022.
URL:https://globalbiodefense.com/event/drug-development-considerations-for-the-prevention-of-healthcare-associated-infections/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20220831T120000
DTEND;TZID=America/Chicago:20220831T130000
DTSTAMP:20220829T173614Z
CREATED:20220829T173614Z
LAST-MODIFIED:20220829T173614Z
UID:56247-1661947200-1661950800@globalbiodefense.com
SUMMARY:Monkeypox: Updates in Evaluation and Management
DESCRIPTION:Discuss the current landscape of Monkeypox in the U.S and infection prevention considerations for evaluation and management in healthcare settings. \nDescribe the clinical presentation in ambulatory and inpatient settings\, as well as the role of supportive and antiviral treatments. \nThis NETEC webinar series presentation will bring together health care practitioners from Massachusetts General Hospital\, Cedars-Sinai\, and NYC Health + Hospitals to share their first-hand experiences caring for patients with monkeypox. Panelists will discuss the current landscape of monkeypox\, infection prevention in health care settings\, and the role of supportive and antiviral treatments in patient care. Panelists will also answer audience questions submitted during webinar registration. \nPANELISTS \nJonathan Grein\, MD\nDirector of Hospital Epidemiology\,\nCedars-Sinai Medical Center\, Los Angeles \nErica S. Shenoy\, MD\nAssociate Chief\, Infection Control Unit\nMedical Director\, Regional Emerging Special Pathogens Treatment Center\nMassachusetts General Hospital \nKevin L. Ard\, MD\, MPH\nDirector\, Sexual Health Clinic\,\nMassachusetts General Hospital\nAssistant Professor\, Harvard Medical School \nPlease visit the NETC website to register for Monkeypox: Updates in Evaluation and Management.
URL:https://globalbiodefense.com/event/monkeypox-updates-in-evaluation-and-management/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://unmc.zoom.us/webinar/register/WN_hETaz1ecTRuqvb_mKoemtg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220922T083000
DTEND;TZID=America/New_York:20220922T170000
DTSTAMP:20220921T183353Z
CREATED:20220921T183322Z
LAST-MODIFIED:20220921T183353Z
UID:56423-1663835400-1663866000@globalbiodefense.com
SUMMARY:VRBPAC Meeting - Rebiotix Indication for Recurrent Clostridioides difficile Infection
DESCRIPTION:The Vaccines and Related Biological Products Advisory Committee (VRBPAC) will convene on 22 September 2022 to discuss the Biologics License Application # 125739 (BLA – 125739) from Rebiotix Inc. for a product\, Rebyota (Fecal Microbiota\, Live)\, with a requested indication to “reduce the recurrence of Clostridioides difficile infection (CDI) in adults following antibiotic treatment for recurrent Clostridioides difficile infection.” \nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. \nThe Docket Number is FDA-2022-N-1608.
URL:https://globalbiodefense.com/event/vrbpac-meeting-rebiotix-indication-for-recurrent-clostridioides-difficile-infection/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=vrahKrbyJaU
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220926
DTEND;VALUE=DATE:20220928
DTSTAMP:20220921T174333Z
CREATED:20220921T174333Z
LAST-MODIFIED:20220921T174333Z
UID:56420-1664150400-1664323199@globalbiodefense.com
SUMMARY:MAQC 2022 - Massive Analysis and Quality Control Society Conference
DESCRIPTION:The 5th Annual Meeting of the FDA/National Center for Toxicological Research (NCTR) – Massive Analysis and Quality Control Society (MAQC) 2022 Conference will be held September 26-27\, 2022\, at the U.S. FDA Headquarters\, White Oak Campus in Silver Spring MD. \nConference presentations\, abstracts\, and discussions will include themes around: Explainable/Reproducible AI/ML\, AI/ML in health-related datasets\, SARS-CoV-2 and public health\, Single-cell\, genomics\, image analysis\, reference samples\, reproducible science and more. \nHighlighted topics and presentations include: \n\nDARPA’s explainable AI (XAI) program: A retrospective\nDrug repurposing for COVID-19 using explainable machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection with real world data validation\nAn automated bioinformatic software testing and benchmarking platform to standardize the development of accurate\, reproducible\, and scalable omics analysis tools\nLeaSH: a High-Throughput COVID-19 Test to Profile Viral and Host Transcriptomes by Next Generation\nSequencing\nSome non-obvious factors that enhance or diminish observed and theoretical Illumina library complexity\nAI or Animal – A reproducibility perspective\nReproducible AI for supporting regulatory applications – a case study\nImproving preclinical pathology analysis with PathologAI\nExplainable approach for species identification using LIME\nEvaluation of mutagenic susceptibility of different stages in germ cell development of Caenorhabditis elegans using next generation sequencing\nIntegrated Calling and Evaluation of Gene Fusion Detection by Targeted RNA Sequencing of Reference Samples with Long and Short Reads\nMutual genome and transcriptome enrichment and sequencing in single cells with ResolveOME amplification chemistry to illuminate complex biological mechanisms\n\nPlease visit the Massive Analysis and Quality Control Society (MAQC) 2022 Conference website for more information and to register.
URL:https://globalbiodefense.com/event/maqc-2022-massive-analysis-and-quality-control-society-conference/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221005
DTEND;VALUE=DATE:20221006
DTSTAMP:20220922T145702Z
CREATED:20220922T145702Z
LAST-MODIFIED:20220922T145702Z
UID:56457-1664928000-1665014399@globalbiodefense.com
SUMMARY:Study Data Standards Update for FDA CBER
DESCRIPTION:FDA’s Center for Biologics Evaluation and Research (CBER)  will host a free virtual format workshop on 5 October 2022 entitled Study Data Standards Update for CBER: Your Guide to a Successful Submission. \nCBER will discuss CBER’s support and requirement starting March 15\, 2023 for the Standard for the Exchange of Nonclinical Data (SEND) \, which was published in the Federal Register on July 14\, 2020\, and the addition of SEND for CBER to the FDA Data Standards Catalog. \nFDA will discuss the brief background of the new requirement and how SEND will aid CBER reviewers. The webinar will also address common issues in submission data. \nINTENDED AUDIENCE\n\nRegulatory science and regulatory affairs professionals working on clinical and non-clinical data submissions for BLAs/NDAs/ANDAs/INDs to CBER\nConsultants focused on clinical and non-clinical data submission\nHealthcare professionals specializing in clinical and non-clinical data\nForeign regulators\n\nFDA RESOURCES\n\nFederal Register Notice regarding SEND for CBER\nFDA Data Standards Catalog\nStudy Data Technical Conformance Guide\nFDA Study Data Standards Resources\nEmail: cber-edata@fda.hhs.gov\n\nPlease visit FDA’s Study Data Standards Update for CBER: Your Guide to a Successful Submission meeting webpage for more information.
URL:https://globalbiodefense.com/event/study-data-standards-update-for-fda-cber/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221011T090000
DTEND;TZID=America/New_York:20221011T120000
DTSTAMP:20220923T194931Z
CREATED:20220923T194822Z
LAST-MODIFIED:20220923T194931Z
UID:56491-1665478800-1665489600@globalbiodefense.com
SUMMARY:Epidemics That Didn't Happen
DESCRIPTION:Join Resolve to Save Lives for a dynamic conversation to mark the release of the second edition of “Epidemics that Didn’t Happen.” This virtual event and new report will illustrate how global and local investments in preparedness\, combined with swift\, strategic responses by public health authorities\, can transform the trajectory of outbreaks\, saving lives and preventing suffering. \nThe latest “Epidemics that Didn’t Happen” report celebrates successful outbreak responses from around the world that demonstrate the returns—in lives saved—of investing in preparedness and response systems. These examples—from Brazil\, Burkina Faso\, Democratic Republic of Congo\, Guinea\, Indonesia\, India and Tanzania—are a testament to the power of preparedness and a roadmap for future success in preventing epidemics. \nCOVID-19 and recent outbreaks of monkeypox and polio have highlighted how vulnerable the world is to infectious diseases. But every day\, public health workers stop epidemics before they start.\nJoin Resolve to Save Lives for a dynamic conversation to mark the release of the second edition of “Epidemics that Didn’t Happen.” This virtual event and new report will illustrate how global and local investments in preparedness\, combined with swift\, strategic responses by public health authorities\, can transform the trajectory of outbreaks\, saving lives and preventing suffering. \n\nWelcome & Opening Remarks – Dr. Tom Frieden\, President and CEO\, Resolve to Save Lives\nKeynote: Reforming Global Health for the Next Pandemic – Precious Matsoso\, former director-general of South Africa’s Department of Health and former chair of the World Health Organization’s Executive Board\nSnapshot of Epidemics that Didn’t Happen\, 2022 – Amanda McClelland\, SVP\, Resolve to Save Lives\nPanel Discussion: Lessons Learned from Successful Outbreak Responses – Featuring: Márcio Garcia\, Health Surveillance Superintendent\, Rio de Janeiro Municipal Health Secretariat ; Representative from Indonesian Red Cross Society (invited)\n\nPlease visit the Resolve to Save Lives’ Epidemics That Didn’t Happen event site for more information.
URL:https://globalbiodefense.com/event/epidemics-that-didnt-happen/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221024T110000
DTEND;TZID=America/New_York:20221024T172000
DTSTAMP:20220905T180114Z
CREATED:20220905T180114Z
LAST-MODIFIED:20220905T180114Z
UID:56285-1666609200-1666632000@globalbiodefense.com
SUMMARY:Board of Scientific Counselors\, National Center for Health Statistics
DESCRIPTION:The CDC has announced the Board of Scientific Counselors\, National Center for Health Statistics (BSC\, NCHS) will convene 24 October 2022 in a live broadcast public meeting. \nThe Board is charged with providing advice and making recommendations to the Secretary\, Department of Health and Human Services; the Director\, CDC; and the Director\, NCHS\, regarding the scientific and technical program goals and objectives\, strategies\, and priorities of NCHS. \nThe meeting agenda will include a Center update by the NCHS Director in addition to updates on NCHS data collection\, analysis\, and reporting activities\, including upcoming changes to the National Hospital Ambulatory Medical Care Survey (NHAMCS); status of a National Ambulatory Medical Care Survey (NAMCS) pilot and plans for obtaining clinician visit data; a new project to improve metadata and catalogs for the public to access restricted use data files; and new releases of linked data sets. The Board’s Workgroup to Consider and Assess Measures of Discrimination for Use in NCHS Surveys will brief the Board with findings from 6 months of information-gathering and assessment work. The Committee will reserve time for public comment at the end of the day. Meeting times and topics are subject to change as priorities dictate. \nMeeting Information: Please visit the BSC\, NCHS website for details. Further information and the meeting agenda will be available on the BSC website\, including instructions for accessing the live meeting broadcast.
URL:https://globalbiodefense.com/event/board-of-scientific-counselors-national-center-for-health-statistics/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221026T140000
DTEND;TZID=America/New_York:20221026T150000
DTSTAMP:20221007T143637Z
CREATED:20221007T143454Z
LAST-MODIFIED:20221007T143637Z
UID:56536-1666792800-1666796400@globalbiodefense.com
SUMMARY:Responding to the Climate Change and Health Crisis: A Framework for Academic Public Health
DESCRIPTION:The Association of Schools and Programs of Public Health (ASPPH) will host a framework launch webinar on Responding to the Climate Change and Health Crisis from 2:00 – 3:00 PM ET on Wednesday\, October 26\, featuring an expert panel that will discuss some of the challenges and opportunities it identifies. \nThe framework examines climate change and health in four primary domains – Education and Training\, Research\, Practice\, and Policy and Advocacy – and considers three cross-cutting themes: Environmental Justice\, Social Justice\, and Health Equity; Interprofessional and Interdisciplinary Collaborations; and Partnerships for Impact. The framework concludes with a set of evidence-based principles and recommendations – for both schools and programs of public health (SPPH) and ASPPH as a whole – to take collective action and work with vested partners to reduce the impacts of climate change on population health. \nThe framework was developed by the ASPPH Task Force on Climate Change and Health\, comprised of experts in a range of climate change and health-related topics from across our member schools and programs\, with feedback from members and partners. In conjunction\, we are also releasing ASPPH’s statement of commitment to addressing climate change and health. \nPlease visit ASPPH for more information.
URL:https://globalbiodefense.com/event/responding-to-the-climate-change-and-health-crisis-framework-for-academic-public-health/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221027
DTEND;VALUE=DATE:20221029
DTSTAMP:20220921T222128Z
CREATED:20220921T222128Z
LAST-MODIFIED:20220921T222128Z
UID:56444-1666828800-1667001599@globalbiodefense.com
SUMMARY:Best Practices: Modeling Approaches to Support Generic Product Development
DESCRIPTION:FDA and the Center for Research on Complex Generics (CRCG) will host a free public workshop on October 27-28\, 2022: Best Practices for Utilizing Modeling Approaches to Support Generic Product Development \nThe purpose of this two-day workshop is to discuss and illustrate how generic product developers can utilize modeling approaches in conjunction with in vitro data and other knowledge to support the development of complex generics that may otherwise rely upon challenging in vivo studies to demonstrate bioequivalence. \nThis workshop will engage experts from regulatory agencies\, the generic drug industry\, consultants\, academia\, and others in the field of modeling and simulation to discuss the opportunities and best practices for incorporating modeling and simulation approaches into generic drug development programs and regulatory submissions. The workshop will also identify commonalities in methodologies/workflows or in silico models supporting alternative BE approaches and clarify how a model master file may be leveraged to advance drug product development\, facilitate regulatory assessment\, and streamline drug product approval. \nFDA and the CRCG—which is a collaboration between the University of Maryland School of Pharmacy and the University of Michigan College of Pharmacy—are dedicated to advancing programs that stimulate scientific dialogue\, disseminate current insights about complex generics\, and generate new knowledge in support of FDA’s mission to promote and protect the public health by increasing access to safe and effective generic medicines. \nHighlighted topics include: \n\nUse of model integrated evidence to support demonstrations of BE in a regulatory context\nUse of the same or similar model or modeling strategy across multiple submissions related to complex drug products\nMechanistic modeling approaches supporting BE assessments for oral drug products\nApplications of quantitative comparative approaches to support the development of complex generic drug products\nCase examples supporting the recently introduced concept of “model master files”\n\nPlease visit the FDA’s Best Practices for Utilizing Modeling Approaches to Support Generic Product Development meeting page for information on registration.
URL:https://globalbiodefense.com/event/best-practices-modeling-approaches-to-support-generic-product-development/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/09/complex-genomics-modeling-approaches-generic-product-fda.jpg
LOCATION:https://umaryland.zoom.us/webinar/register/WN_QLkZn5TbTYqu4F986aKD6g
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221027T140000
DTEND;TZID=America/New_York:20221027T150000
DTSTAMP:20221025T173153Z
CREATED:20221025T173153Z
LAST-MODIFIED:20221025T173153Z
UID:56589-1666879200-1666882800@globalbiodefense.com
SUMMARY:Public Health Workforce Calculator: Staffing up to Achieve Foundational Services
DESCRIPTION:In 2021\, an analysis of the public health workforce found that state and local governmental public health departments need an 80% increase in their workforce to provide a minimum set of public health services to the nation. In response to this gap\, the Public Health National Center for Innovations at PHAB\, de Beaumont Foundation\, and the Centers for Disease Control and Prevention’s Center for State\, Tribal\, Local and Territorial Support developed the Public Health Workforce Calculator to aid local health departments in estimating staffing needs to provide the Foundational Public Health Services in their community. Join us on October 27th at 2PM ET to learn more about the Calculator and how it can contribute to workforce staffing needs and planning for public health funding. \nWebinar Objectives\n– Describe how the analysis was used to successfully build support for health departments\n– Explain the intended use of the recently released Public Health Workforce Calculator.\n– Demonstrate how to use the Calculator\, including identifying the Calculator’s best use cases.
URL:https://globalbiodefense.com/event/public-health-workforce-calculator-staffing-up-to-achieve-foundational-services/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://us02web.zoom.us/webinar/register/1316650817717/WN_273HybPhTfOA1Df_brsQNQ
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221102
DTEND;VALUE=DATE:20221104
DTSTAMP:20220922T163745Z
CREATED:20220922T163745Z
LAST-MODIFIED:20220922T163745Z
UID:56469-1667347200-1667519999@globalbiodefense.com
SUMMARY:Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting
DESCRIPTION:On November 2\, 2022\, the committee will discuss the Center for Drug Evaluation and Research (CDER) Quality Management Maturity (QMM) program. QMM is the state attained when drug manufacturers have consistent\, reliable\, and robust business processes to achieve quality objectives and promote continual improvement. CDER has proposed the development of a rating system that will help incentivize drug manufacturers to adopt more mature quality management practices at their facilities. The committee will consider the impact that a QMM program would have on the pharmaceutical industry\, drug shortages\, and supply chain resiliency. FDA will seek input to determine if experts from academia and industry support the development of a CDER QMM program to incentivize investments in mature quality management practices. \nOn November 3\, 2022\, as part of CDER’s continued effort to provide key updates on modernization of quality assessment\, the committee will discuss the next stages of Knowledge-Aided Assessment and Structured Application (KASA). The concept of KASA was envisioned in 2016 and discussed at the Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting on September 20\, 2018\, as an IT system that modernizes FDA’s assessment. Through the development\, testing\, and implementation of various KASA prototypes\, the KASA system has been refined over the course of multiple years. FDA will seek input on the vision and plan to expand KASA over the next 5 years to include drug substances\, all generic dosage forms\, new drug and biologics applications\, and post-approval changes. Moreover\, FDA will seek input regarding the need for advancing digitalization in KASA\, including data standardization and mobilization of data from cloud-based servers. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The docket number is FDA-2022-N-1777. \nPlease visit the FDA’s Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting Announcement page for more information.
URL:https://globalbiodefense.com/event/pharmaceutical-science-and-clinical-pharmacology-advisory-committee-meeting/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221114
DTEND;VALUE=DATE:20221117
DTSTAMP:20220922T160410Z
CREATED:20220922T160410Z
LAST-MODIFIED:20220922T160410Z
UID:56460-1668384000-1668643199@globalbiodefense.com
SUMMARY:Regulatory Framework for Distributed and Point of Care Pharmaceutical Manufacturing
DESCRIPTION:The FDA and Product Quality Research Institute (PQRI) will host a webcast workshop on the Regulatory Framework for Distributed and Point of Care Pharmaceutical Manufacturing on 14-16 November 2022. \nFuture pharmaceutical manufacturing may occur not only in large manufacturing facilities; it may occur in smaller\, more geographically distributed facilities or even at the point of care. The National Academies of Sciences\, Engineering\, and Medicine noted in a 2021 report that FDA is likely to see substantial innovations in integrated\, flexible\, and distributed manufacturing (DM). These innovations include modular approaches to streamline drug and biologic production and the deployment and use of highly portable manufacturing units that could enable point of care (POC) manufacturing. These types of technologies may challenge the traditional approaches to regulating pharmaceutical manufacturing. \nFDA has also encountered the rapid emergence of advanced manufacturing technologies in various investigational biological products\, such as tissue-based\, cell and gene advanced therapy products\, intersecting with critical areas associated with DM and POC manufacturing. Such biologics are generally more complex with undefined critical quality attributes and often have different manufacturing paradigms. This is particularly true for cellular and gene therapy products and tissue-engineered products. \nThe Workshop aims to facilitate interaction among DM/POC stakeholders on critical areas for development and implementation of these technologies including terminology\, technical challenges to adoption\, operation of Pharmaceutical Quality Systems\, good manufacturing practice expectations\, and the unique challenges and considerations that apply to complex biologics. \nPlease visit PQRI’s Regulatory Framework for Distributed and Point of Care Pharmaceutical Manufacturing website for more information. \n 
URL:https://globalbiodefense.com/event/regulatory-framework-for-distributed-and-point-of-care-pharmaceutical-manufacturing/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230504T080000
DTEND;TZID=America/New_York:20230504T120000
DTSTAMP:20230501T154445Z
CREATED:20230501T153634Z
LAST-MODIFIED:20230501T154445Z
UID:57174-1683187200-1683201600@globalbiodefense.com
SUMMARY:Prioritizing Actions for Epidemic and Pandemic Preparedness
DESCRIPTION:The Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium will be held 4 May and 18 May 2023. \nThis first session will be held from 8:00am-12:00pm ET on 4 May 2023 and the second session from 8:00 am-12:00pm ET on 18 May 2023. \nThe purpose of this symposium is to convene global health planning stakeholders\, including those in government and academia\, and across health- and non-health sectors\, to strengthen the capacity for evidence-based prioritization of global health capabilities. Objectives of this meeting are the following: \n\nReview assessment tools and how\, independently and together\, they relate to national action planning.\nGain insight into how countries and organizations currently select priorities in funding for epidemic prevention\, detection\, and response.\nAssess evidence for effective prioritization approaches to building disease surveillance and risk communication capabilities.\nIdentify governance structures that can support robust and reliable systems for global health investments.\n\nAGENDA\nPolitical and Economic Context for Sustainable International Epidemic Preparedness: International Governance and Finance (Session 1)\nThe goal of this forward-looking discussion is to highlight critical needs\, challenges\, and gaps in international and national governance and financing for developing and maintaining critical capabilities needed to prevent\, detect\, and respond to future epidemics. \nModerator: Dr. Mercy Mwangangi\, AMREF Kenya \nSpeakers:\nRaj Panjabi\, White House National Security Council\nSara Hersey\, World Health Organization Health Emergencies\nPriya Basu\, Pandemic Fund Secretariat\, World Bank Group\nSaul Walker\, Coalition for Epidemic Preparedness Innovations (CEPI) \nPolitical and Economic Context for Sustainable International Epidemic Preparedness: Regional and Country Efforts and Building Trust (Session 2)\nThe goal of this forward-looking discussion is to highlight critical needs\, challenges\, and gaps in science\, public health\, and health security for strengthening and maintaining critical capabilities needed to prevent\, detect\, and respond to future epidemics. \nModerator: Dr. Mercy Mwangangi\, AMREF Kenya \nSpeakers:\nAyoade Alakija\, African Vaccine Delivery Alliance\, Pre-recorded Video\nIrma Makaliano\, University of the Philippines\nDuncan Selbie\, International Association of National Public Health Institutes\nJailson Correia\, Instituto de Medicina Integral Professor Fernando Figueira\nWessam Mankoula\, Africa Centers for Disease Control \nAction Groups Preview \n\nSituational Awareness in the Context of Health and Diseases: Larry Brilliant\, Pandefense Advisory\nBuilding Trust\, Transparency\, and Risk Communication Capabilities: Richard Garfield\, US Centers for Disease Control and Prevention\nStrengthening Global Health Security through Strong Country-Level Infrastructure for Effective Governance\, Financing\, and Accountability: Julie Wahl\, Resolve to Save Lives\nGlobal Health Capacity and Functionality Assessment: Jessica Petrillo\, US Agency for International Development\nCountries’ and Organizations’ Experiences in Preparedness and Response Planning: Erwin Calgua\, Universidad de San Carlos de Guatemala\n\nPlease visit the National Academies’ Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium page for more information and to register for virtual attendance.
URL:https://globalbiodefense.com/event/prioritizing-actions-for-epidemic-and-pandemic-preparedness/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230518T080000
DTEND;TZID=America/New_York:20230518T120000
DTSTAMP:20230501T154139Z
CREATED:20230501T153817Z
LAST-MODIFIED:20230501T154139Z
UID:57177-1684396800-1684411200@globalbiodefense.com
SUMMARY:Prioritizing Actions for Epidemic and Pandemic Preparedness
DESCRIPTION:The Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium will be held 18 May 2023. \nThis is the second of two sessions. The purpose of this symposium is to convene global health planning stakeholders\, including those in government and academia\, and across health- and non-health sectors\, to strengthen the capacity for evidence-based prioritization of global health capabilities. \nObjectives of this meeting are the following: \n\nReview assessment tools and how\, independently and together\, they relate to national action planning.\nGain insight into how countries and organizations currently select priorities in funding for epidemic prevention\, detection\, and response.\nAssess evidence for effective prioritization approaches to building disease surveillance and risk communication capabilities.\nIdentify governance structures that can support robust and reliable systems for global health investments.\n\nAGENDA\nHealth Security Action Areas: Issues and Opportunities\nThe goals of these discussions are to review success and failures\, use of assessment tools\, identify outstanding gaps and determine critical areas for action to sustainably improve capabilities in three areas. \nSituational Awareness in the Context of Health and DiseasesThe goal of this discussion is to re-set expectations at a higher-level of what can be done to keep both public health and the general public aware of changes in disease risks as early as possible by combining many current surveillance systems with new sources of disease data to form near real time awareness of constantly changing disease risks. \nTopics covered in this discussion include: \n\nCurrent tools for disease surveillance and the international tools used to evaluate the effectiveness of these systems\nRoutine methods and genetic surveillance for assessing situational awareness\nRecent innovations in detection in detection of novel diseases and use of closer-to-real-time monitoring of critical changes in endemic disease\nRecent experience including new types of disease surveillance and combinations of traditional and new methods to improve situational awareness\nIntegration of surveillance tools to realize near-real-time situational awareness\n\nModerator: Larry Brilliant\, Pandefense Advisory \nDiscussants:Mark Smolinski\, Ending PandemicsPatipat Keng Susumpow\, Opendream CoChanne Suy\, Co–Founder\, Kawsang \nBuilding Trust\, Transparency\, and Risk Communication Capabilities\nThe goal of this discussion is to review existing guidance and frameworks for risk communication\, highlighting approaches that are particularly effective for communicating risk about epidemics and describing approaches that have been demonstrated to be less effective or ineffective in communicating risks. \nModerator: Richard Garfield\, U.S. Centers for Disease Control and Prevention \nDiscussants:\nKatelyn Jetelina\, Your Local Epidemiologist\nRania Elessawi\, UNICEF\nBaruch Fischhoff\, Carnegie Mellon University \nStrengthening Global Health Security through Strong Country-Level Infrastructure for Effective Governance\, Financing\, and Accountability\nA country’s performance during an infectious disease outbreak is only as strong as its ability to leverage multisectoral partnerships; coordinate at national\, subnational and community levels; and continuously develop and strengthen health and public health system capacity to prevent and respond to outbreaks. \nThe goal of this discussion is to examine how improving global health security begins at the country-level and how countries can strengthen their public health architecture for epidemic preparedness and response through effective mechanisms for governance\, financing\, and accountability. This group will focus on the following questions: \n\nHow might countries /organizations ensure effective multisectoral governance at country-level?\nHow might countries /organizations foster accountability among partners and stakeholders that drives continuous quality improvement and well-prioritized investments?\n\nModerators\nJulie Wahl\, Resolve to Save Lives\nGisela Scaglia\, Former Member of Parliament Argentina \nDiscussants\nAminu Magashi Garba\, Africa Budget Network\nImmaculate Nabukenya\, Makerere University\nAbrham Ejigu – Senior Project Manager\, Resolve to Save Lives\, Ethiopia \nCross-Cutting Action Areas: Issues and Opportunities\nThe goals of these discussions are to review success and failures\, use of assessment tools\, identify outstanding gaps and determine critical areas for action to sustainably improve capabilities in three overarching areas \nGlobal Health Security Capacity and Functionality Assessment\nTimely access to quality\, actionable data underpins effective prioritization of investments to address GHS capacity and functionality gaps. The goal of this session is to discuss and identify critical needs\, challenges\, gaps\, and\nopportunities to improve GHS capacity and functionality assessment tools\, their use\, and the use of the data they generate to inform decision making on strengthening and maintaining critical capabilities needed to prevent\, detect\, and respond to any future epidemics. Participants will discuss the following issues: \n\nIdentify challenges in the use of existing tools (including accessibility) and opportunities to improve them.\nIdentify opportunities to improve interoperability\, interconnectedness\, and integration of assessment tools and data.\nIdentify opportunities to improve linkages between capacity/capability guidance and assessment tools.\nParticipants will have a worksheet to contribute to prior to and following the discussion.\nParticipants will use Jamboard to add suggested actions for addressing identified gaps.\n\nModerators\nAamer Ikram\, National Institutes of Health Pakistan\nJessica Petrillo\, U.S. Agency for International Development \nDiscussants:\nAnne Liu\, Gates Ventures\nDr. Magda Robalo Correia e Silva\, Institute for Global Health and Development\nCharles Bebay\, ECTAD Regional Manager for Eastern and Southern Africa\,\nFood and Agriculture Organization \nCountries’ and Organizations’ Experiences in Preparedness and Response Planning\nThe goal of this discussion is to identify lessons and best practices for preparedness and response at the national level\, and identify actions on policy and practice for improving preparedness and planning for the next pandemic by learning from what went well and what went less well in national contexts. \nExamples exist of countries on good planning practices to address the SARS-CoV-2 pandemic. These countries have observed strong and weak points in the national system through systematic monitoring and evaluation (M&E) tools (e.g.\, IHR\, Joint External Evaluation\, Universal Health and Preparedness Review). Before engaging in discussion about these topics\, participants will hear from two examples of countries from different perspectives. This discussion will focus on the following questions: \n\nWhat are the actual practices in a term of multisectoral approach that the country is adopting as a result of learning in this symposium from the M&E tool?\nWhat’s the nature of the reinforcement process of preparedness and response planning at the national level?\n\nParticipants will be asked to suggest approaches and actions to guide each country’s decision to implement and strengthen the use of their preparation and response plans with academia\, donors\, and private partners. \nModerators\nSoawapak Hinjoy\, Department of Disease Control\, Ministry of Health\, Thailand\nErwin Humberto Calgua Guerra\, Universidad de San Carlos de Guatemala\nArminder Kaur Deol\, Coalition of Epidemic Preparedness Innovations \nDiscussants:\nJeffery Cutter\, Ministry of Health Singapore\nAli Ardalan\, Health Systems in Emergencies Lab\, World Health Organization\nRegional Officer for the Eastern Mediterranean \nPlease visit the National Academies’ Prioritizing Actions for Epidemic and Pandemic Preparedness Virtual Symposium page for more information and to register for virtual attendance.
URL:https://globalbiodefense.com/event/prioritizing-actions-for-epidemic-and-pandemic-preparedness-2/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230628T120000
DTEND;TZID=Europe/Paris:20230628T133000
DTSTAMP:20230622T143901Z
CREATED:20230622T143901Z
LAST-MODIFIED:20230622T143901Z
UID:57247-1687953600-1687959000@globalbiodefense.com
SUMMARY:One Health Priority Research Agenda for AMR
DESCRIPTION:The One Health Priority Research Agenda for AMR Report launch event will take place on 28 June 2023. This is a joint initiative to assist in directing and catalyzing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. \nThe lead organizations working in the multilateral system on human\, animal\, plant and environmental health\,  the UN Environment Programme (UNEP)\, the Food and Agriculture Organization of the United Nations (FAO)\, the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) joined forces to advance international co-operation for a One Health response on AMR. \nThese Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report\, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The research agenda also serves as a guide to mitigate One Health AMR that will help policymakers\, researchers\, and a multidisciplinary scientific community work together on solutions to prevent and mitigate AMR within the One Health approach. \nAGENDA \n12:00-12:05 Welcome and scene setting\, Sarah Nehrling Moderator \n12:05-12:20 Presentation of the One Health Priority Research Agenda for Antimicrobial Resistance\, Haileyesus Getahun\, Director\, Quadripartite Joint Secretariat on AMR\, WHO \n12:20-13:15 Moderated panel discussion on the implications of the One Health Priority Research Agenda for Antimicrobial Resistance for the different sectors and stakeholders Speakers (3-5 minutes) \n\nMaria Helena Semedo\, Deputy Director General\, Food and Agriculture Organization of the United Nations (FAO)\nJacqueline Álvarez\, Chief\, Chemicals and Health Branch\, Economy Division\, United Nations Environment Programme (UNEP)\nHanan H Balkhy\, Assistant Director General for Antimicrobial Resistance\, World Health Organization (WHO)\nMontserrat Arroyo Kuribreña\, Deputy Director General\, International Standards and Science\, World Organisation for Animal Health (WOAH)\nRobert Skov\, Scientific Director at the International Center for Antimicrobial Resistance Solutions (ICARS)\nScott Weese\, Professor in the Department of Pathobiology\, Director of the Centre for Public Health and Zoonoses\, University of Guelph\, Global Leaders Group member on AMR\nSabiha Essack\, Professor in the South African Research Chair (SARChI) in Antibiotic Resistance and One Health and Professor in Pharmaceutical Sciences at the University of KwaZulu Natal (UKZN)\n\n13:15-13:25 Qs&As with the audience \nParticipate virtually in the webinar to launch the One Health Priority Research Agenda for AMR due to take place on 28 June 2023 from 12:00 to 13:30 CET. Please visit UN Environment Programme’s One Health Priority Research Agenda for AMR Report launch event to register.
URL:https://globalbiodefense.com/event/one-health-priority-research-agenda-for-amr/
CATEGORIES:Webinar-Webcast
LOCATION:https://who.zoom.us/webinar/register/WN_YgvxO3sgQvmdNYfZERfscQ#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230907
DTEND;VALUE=DATE:20230909
DTSTAMP:20230905T152717Z
CREATED:20230805T152440Z
LAST-MODIFIED:20230905T152717Z
UID:59045-1694044800-1694217599@globalbiodefense.com
SUMMARY:Genomics and Precision Public Health Issues Enrichment Event
DESCRIPTION:The Oak Ridge Institute for Science and Education (ORISE) will host a Genomics and Precision Public Health Issues Enrichment Event from 7-8 Sep 2023 in Atlanta\, Georgia. \nIn the past decade\, genomics\, and precision health approaches such as big data science and machine learning have emerged as important tools for public health. Those entering the public health and medical workforces must keep pace with these evolving fields to maximize the benefit to public health. Recognizing this need\, ORISE is partnering with the Office of Genomics and Precision Public Health at the Centers for Disease Control and Prevention to offer a two-day in-person enrichment event covering the latest developments in these fields. \nThe course will consist of a series of 15-60 minute lectures\, grouped by topic\, with learning objectives for each lecture. The course will be freely available to all ORISE fellows and will also be available for online viewing after the event. Online materials will include a video recording of each lecture\, a slide presentation\, and\, for some lectures\, recommended readings and questions for discussion and knowledge assessment. \nHighlighted topics include: \n\nGenomics in the Practice of Medicine and Public Health\nPathogen Genomics and new Precision Public Health Tools for Infectious Diseases and Outbreak Response\nPharmacogenomics – Because Every Person in the Population is Important and Unique\nEffective Use of Behavioral\, Communication and Social Sciences for Precision Public Health\nHarnessing Big Data and Precision Medicine – Intelligent & Integrative Data Analysis for Health Impact\nPrecision Public Health Surveillance and Machine Learning – Better Tools to Tackle Old and New Challenges\nPopulation Based Genomic Screening – Are We Ready?\nImplementation Science – A Critical Element of Precision Public Health\nGenomic Epidemiology: Linking Precision Health and Populations\nMeasurement of Health Equity in Public Health Investigations\nPrecision Public Health as a Primary Strategy for Reaching Health Equity\nEffective Educating of Providers in Precision Public Health\n\nRegistration for the in-person event is capped at 200 attendees\, with preference given to the order in which registrations are received. There is no cost to register. Travel to and from the event is the responsibility of the attendee and their program. \nPlease visit ORISE’s Genomics and Precision Public Health Issues Enrichment Event to register.
URL:https://globalbiodefense.com/event/genomics-and-precision-public-health-issues-enrichment-event/
LOCATION:Atlanta Marriott Buckhead Hotel\, 3405 Lenox Road NE\, Atlanta\, GA\, 30326\, United States
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230929T100000
DTEND;TZID=America/New_York:20230929T113000
DTSTAMP:20230920T192004Z
CREATED:20230820T191510Z
LAST-MODIFIED:20230920T192004Z
UID:59298-1695981600-1695987000@globalbiodefense.com
SUMMARY:The Long Journey to Eliminate the Deadly U.S. Chemical Weapons Stockpile
DESCRIPTION:The CWC Coalition will host a webinar entitled ‘The End of an Era: The Long Journey to Eliminate the Deadly U.S. Chemical Weapons Stockpile’ on 29 September 2023. \nWhen the United States ratified the Chemical Weapons Convention (CWC) in 1997\, it took on the legal obligation and the complex technical and engineering task of destroying its massive Cold War-era chemical weapons stockpile\, which consisted of some 31\,500 tons (63\,000\,000 pounds) of deadly chemical agents much of which were loaded in various forms of munitions. \nAfter years of delay\, all U.S. declared chemical weapons stockpiles were irreversibly and verifiably destroyed in July 2023\, two months ahead of the Sept. 2023 deadline set by the Organization for the Prohibition of Chemical Weapons (OPCW). \nThe event is a major milestone in disarmament: the United States was the last declared stockpile possessor state to complete its safe and permanent demilitarization of chemical weapons. \nOn Sept. 29\, this webinar will feature perspectives from a senior Defense Department official on the long path to successfully eliminate the U.S. chemical arsenal\, and the experiences of two local leaders who worked to reshape the government’s original plans for chemical weapons destruction to reduce the risks to local communities where the U.S. stockpiles were once stored. \nSpeakers: \n\nKingston Reif\, deputy assistant secretary of defense for threat reduction and arms control\nIrene Kornelly\, chair of the Colorado Citizens’ Advisory Commission\nCraig Williams\, co-chair of the Kentucky Citizens’ Advisory Commission\nDaryl Kimball\, executive director\, Arms Control Association\, moderating\n\nThis discussion will be on the record. The webinar is organized by the Arms Control Association and the Chemical Weapons Convention Coalition. \nRSVP via Zoom
URL:https://globalbiodefense.com/event/the-long-journey-to-eliminate-the-deadly-u-s-chemical-weapons-stockpile/
CATEGORIES:Webinar-Webcast
LOCATION:https://us02web.zoom.us/webinar/register/7416946160158/WN_N3yOaJhBTaOPVD9IB80z-g#/registration
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231003
DTEND;VALUE=DATE:20231006
DTSTAMP:20230916T150439Z
CREATED:20230916T150439Z
LAST-MODIFIED:20230916T150439Z
UID:59214-1696291200-1696550399@globalbiodefense.com
SUMMARY:OneLab Summit 2023
DESCRIPTION:The CDC will host the OneLab Summit 2023 from 3-5 October 2023 online. This free\, three-day virtual summit connects laboratory professionals in real time to support a unified response to laboratory training needs. \nAttendance is open to anyone interested or involved in the laboratory profession. OneLab Summit programming is most relevant to people who provide education or training to clinical and public laboratory professionals. \nHighlighted topics include: \n\nMaximizing Lessons Learned from Past Outbreaks to Develop a Sustainable Laboratory Cross-training Program\nBiosafety Plan: Preparing Your Laboratory to Handle Emerging and Re-Emerging Pathogens\nHow Laboratories Should Prepare for Future Responses\nEvaluating Your Laboratory’s Risk Management Process Or Quality Improvement Process\nThe Role and Importance of DEIAB in Public Health Workforce Development to Advance Health Equity\nInterconnecting People for Planning and Preparedness\nOneLab REACH – What’s New and What’s Ahead\nUnderstanding CLIA and CAP Regulations to Advance Your Laboratory Career\nCreating a Training Needs Assessment For Your Laboratory\nLaboratory Staffing and Retention\nInnovative Student Recruitment to MLS and MLT Programs\n\nThis year\, OneLab Summit will feature a Virtual Exhibit Hall. Attendees can use this online space to highlight their organization’s programs\, resources\, success stories\, and more. \nPlease visit CDC’s OneLab Summit 2023 website to register.
URL:https://globalbiodefense.com/event/onelab-summit-2023/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://cdc.zoomgov.com/webinar/register/WN_tANOotpLSduPLwmczNXDVA#/registration
END:VEVENT
END:VCALENDAR